Investors have poured over $5.5 Million into a little known oil & gas name that is slowly making the rounds on Wall Street. They’re betting this company strikes oil in one of their many properties and becomes Exxon’s next takeout target. Who are we talking about? Read on… US Oil Production Will Hit […]
Curis, Inc. (NASDAQ: CRIS) – brief chart analysis for you – lots of room to grow Play on your own risk. About Curis, Inc. Curis, Inc., (NASDAQ: CRIS) a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. The company develops CUDC-907, […]
Chart/Volume Play – be sure that you read Curis’s PR beforehands: Curis, Inc. (CRIS), a biotechnology company, announced on September 14th, 2014 the pricing of an underwritten public offering of 20,000,000 shares of its common stock (the “Offering”). The Offering is expected to close on or about September 18, 2017, subject to customary closing conditions. […]
Congratulations on a trading with ParkerVision, Inc. (NASDAQ: PRKR) – PennyStockHaven followers enjoyed over 20% gains just in a three short weeks. Here is a new trading idea for technical re-bounce: Ocean Power Technologies, Inc. (NASDAQ: OPTT) Please note: this is a big P o S (sorry for my French) but anyhow: Ocean Power Technologies (Nasdaq: […]
Congratulations on a trade with Ritter Pharma (NASDAQ : RTTR). Today Ritter (Company) announced that the U.S. Food and Drug Administration (FDA) has agreed to schedule an end of phase 2 meeting with the company which is expected to take place in the third quarter of 2017. The Company plans to discuss the results of […]
Trading opportunity – RTTR– don’t miss it. As usual – risky hence play it with guts. Shares Outstanding 11.62M Float 7.5M % Held by Insiders 30.71% % Held by Institutions 25.80% Shares Short 564920 (source – yahoo finance) Ritter Pharmaceuticals Announces Lactose Intolerance Treatment, RP-G28, Demonstrated Efficacy and Clinically Meaningful Benefit in Phase 2b/3 Clinical […]
Great trade on Approach Resources Inc. (AREX), and now is: Gevo, Inc. (GEVO): hugely diluted, heavily shorted, offered shares partially absorbed, should be seen a light at the end of tunnel… Gevo Announces Pricing of $11.9 million Public Offering of Common Stock and Warrants ENGLEWOOD, Colo., Feb. 14, 2017 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ:GEVO) […]
AREX – heavily shorted, earnings are coming (is anyone with a little Martha Stewart info leak around?), dilutive filings: FORT WORTH, Texas, Jan. 30, 2017 (GLOBE NEWSWIRE) — Approach Resources Inc. (AREX) (“Approach” or the “Company”) today announced the commencement of an offer (“Exchange Offer”) to exchange newly issued shares of its common stock, par […]
A few facts… Excerpts from the Company’s Financial Results for the Third Quarter Ended September 30, 2016: Total operating expenses for the quarter ended September 30, 2016 were $1,801,000, a decrease of 48.5% compared to $3,500,000 for the same period in 2015. This decrease was primarily due to a reduction of compensation related expenses, consultant […]
We are rarely re-posting articles but… no way to say better that Pros do: Silimed: Particles and Polymers – Professor J D Frame, Dr M Olivan The recent release of censured but commercially sensitive information on particle surface contamination of silicone implants via the Silimed information centre , the MHRA (Medicines and Healthcare Regulatory Agency), […]
